申请人:Sakuma Shogo
公开号:US20110092703A1
公开(公告)日:2011-04-21
A P2X
4
receptor antagonist is a compound represented by the formula (I) or a pharmacologically acceptable salt thereof, which is used as a preventive or therapeutic agent for neuropathic pains:
Wherein B is aryl or the like that can have a substituent; Y is C
1-5
alkylene that can have a double bond; Z is O, S or the like; each of R
1
, R
2
and R
3
independently is hydrogen, C
1-8
alkyl or the like; R
4
is hydrogen, C
1-8
alkyl or the like; each of P and Q independently is hydrogen, halogen, C
1-8
alkyl or the like; W is C
1-8
alkyl or the like; and each of n and m independently is 1 or 2.
一种P2X4受体拮抗剂,其化学式表示为(I),或其药理学上可接受的盐,可用作神经病理性疼痛的预防或治疗剂:其中,B是芳基或类似物,可以有取代基;Y是C1-5烷基,可以具有双键;Z是O、S或类似物;R1、R2和R3各自独立地是氢、C1-8烷基或类似物;R4是氢、C1-8烷基或类似物;P和Q各自独立地是氢、卤素、C1-8烷基或类似物;W是C1-8烷基或类似物;n和m各自独立地为1或2。